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Lung transplantation for suppurative diseases
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PM Pêgo Fernandes1, FB Jatene4
From 23rd World Congress of the World Society of Cardio-Thoracic Surgeons
Split, Croatia. 12-15 September 2013
Background
Bronchiectasis may be associated to chronic respiratory
failure, whereas lung transplantation (LTx) is the only
long term treatment. According ISHLT registries, cystic
fibrosis (CF) is the third cause for LTx (16.8%) and the
best survival in five years (60%). Non-CF bronchiectasis
corresponds to only 2.8% The aim of this study is to
describe our experience with LTx for patients with sup-
purative diseases.
Methods
Between 2000 and 2011, the charts of all patients who
underwent LTx for suppurative diseases were reviewed.
Results
Of 150 LTx performed, 59 patients (39.3%) had suppura-
tive diseases, 29 (19.3%) were non-CF and 30 (20%) had
CF. In non-CF group, mean age was 40.2 ± 12.6 years,
male predominance (58.3%) and all bilateral. Pulmonary
hypertension was present in 50%, but cardiopulmonary
bypass (CPB) used n 13.8%. None case of PGD3 was seen
in this group. CF patients were younger (27.4 + 9.2 years),
53% males and almost all bilateral (97%). 30% had pul-
monary hypertension, CPB used in 10% and 10% devel-
oped PGD3 . There were no difference in ventilation time,
ICU and hospital stay. The survival rate at 1 and 5 years in
CF was 92% and 77% and in non-CF was 84% and 75%.
There was no difference according survival but these both
groups showed better survival than other underlying dis-
eases (p < 0.001).
Conclusions
Suppurative diseases are important source of patients
for LTx in our program. The incidence of non-CF
bronchiectasis is especially high corresponding to the
forth indication. The survival rates of these both groups
are excellent and comparable to other reports.
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